# Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft

> **NCT03887156** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 227 (estimated)

## Conditions studied

- Acute Myeloid Leukemia in Remission
- Lymphoma in Remission
- Non-progressive Myeloproliferative Syndrome
- Myelodysplasia With Stable Blasts is Cell Number and < 10% of Blastocysts
- Acute Leukemia Biphenotypic in Remission
- Acute Lymphoblastic Leukemia

## Interventions

- **DIAGNOSTIC_TEST:** Ex vivo capacities of CD4neg INkT expansion of the peripheral blood donor with the Predictor test

## Key facts

- **NCT ID:** NCT03887156
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-16
- **Primary completion:** 2023-03-16
- **Final completion:** 2023-03-16
- **Target enrollment:** 227 (ESTIMATED)
- **Last updated:** 2021-09-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03887156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03887156, "Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03887156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*